Ads
related to: mckesson price list
Search results
Results From The WOW.Com Content Network
McKesson Provider Technologies is the retail name for McKesson Technology Solutions; the software development division of McKesson. Their customer base in the United States includes 50% of all health systems, 20% of all physician practices, 25% of home care agencies, and 77% of health systems with more than 200 beds.
A consumer coalition filed separate suits in a Boston, Massachusetts federal court against drug wholesaler McKesson Corporation and First Databank, accusing the companies of artificially inflating drug prices. The lawsuits say that McKesson and FDB conspired from 2002 through 2005 to set the list prices artificially high.
By 2012 the price of a vial of Acthar was $28,400. [90] and was considered to be one of the world's most expensive drugs in 2013. By 2014 the price of Gilead's specialty drug for hepatitis C, Sovaldi or sofosbuvir, was $84,000 to $168,000 for a course of treatment in the U.S., £35,000 in the UK for 12 weeks. [92]
Prescription drug list prices in the United States continually are among the highest in the world. [1] [2] The high cost of prescription drugs became a major topic of discussion in the 21st century, leading up to the American health care reform debate of 2009, and received renewed attention in 2015.
McKesson Canada purchased Rexall in December 2016 for $3 billion from the Katz Group of Companies. [4] At the time, it was estimated that Rexall had an average annual revenue of approximately $2.0 to $2.5 billion. [5] Around this period, one of the major rival pharmacies in Canada was Shoppers Drug Mart. [6]
McKesson would acquire about a 70% stake in the unit, which would be part of its U.S. pharmaceutical segment. Upon the close of the transaction, Florida Cancer Specialists — which operates in ...